These innovative MOTS-c Peptide medications , Retatrutide, represent a groundbreaking advancement in managing type 2 diabetes and potentially related ailments . They are categorized as GLP-1 receptor agonists , meaning these substances to mimic the body's GLP-1 substance , stimulating metabolic release and reducing hunger . While Retatrutide each o